| 1995 |
FAF1 was identified as a protein that specifically interacts with the cytoplasmic domain of wild-type Fas but not the lprcg-mutated Fas, and potentiates Fas-induced apoptosis when transiently expressed in L cells. |
Yeast two-hybrid screen, mammalian co-immunoprecipitation, transient overexpression with apoptosis readout |
Proceedings of the National Academy of Sciences of the United States of America |
High |
8524870
|
| 2003 |
FAF1 is a member of the Fas-DISC, interacting with FADD and caspase-8 via their death effector domains (DEDs) binding the amino acid 181-381 region of FAF1. FAF1 colocalizes with Fas at the cytoplasmic membrane before Fas activation and moves to the cytoplasm after activation. A dominant-negative FAF1 deletion mutant lacking the N-terminus protects cells from Fas-induced apoptosis, and FAF1-mediated cell death is suppressed in FADD- and caspase-8-deficient cells, placing FAF1 upstream of caspase-8. |
Co-immunoprecipitation (in vivo and in vitro), confocal microscopy, dominant-negative overexpression, genetic epistasis in FADD/caspase-8-deficient Jurkat cells |
The Journal of biological chemistry |
High |
12702723
|
| 1999 |
Human FAF1 (hFAF1) was identified and characterized; the N-terminal region (amino acids 1–201) including the upstream ubiquitin homology domain binds to the death domain of Fas but not to the lprcg mutant Fas. |
GST pulldown with in vitro translation product of Fas, cDNA cloning |
Biochemical and biophysical research communications |
Medium |
10462485
|
| 2001 |
Apoptosis induced by hFAF1 overexpression requires its ubiquitin homologous domain (UB2) and adjacent nuclear localization signal, but not the Fas-binding domain, indicating an intrinsic apoptotic activity independent of Fas binding. |
Transient overexpression of deletion mutants, apoptosis assays (membrane blebbing, phosphatidylserine exposure, caspase-3 activation) |
Biochemical and biophysical research communications |
Medium |
11527403
|
| 2001 |
Protein kinase CK2 phosphorylates FAF1 in vitro at Ser289 and Ser291, and CK2 is the major cellular kinase responsible for FAF1 phosphorylation in cell extracts. |
In vitro kinase assay with recombinant CK2, MALDI-MS identification of phosphorylation sites, tissue extract kinase assay |
The international journal of biochemistry & cell biology |
High |
11378439
|
| 2003 |
CK2 phosphorylates FAF1 at Ser289 and Ser291 in vivo (at least one site confirmed), and phosphorylation-deficient FAF1 mutants show delayed nuclear import compared to wild-type FAF1, without affecting FAF1's ability to potentiate Fas-induced apoptosis. |
In vivo phosphorylation analysis, nuclear import assay with phosphorylation-deficient mutants |
FEBS letters |
Medium |
12832043
|
| 2004 |
FAF1 selectively coactivates mineralocorticoid receptor (MR)-mediated transcription but does not transactivate glucocorticoid receptor (GR), as shown by yeast two-hybrid interaction and transient transactivation assays in mouse hippocampal cells. |
Yeast two-hybrid screen, transient transactivation assays in mammalian neural cells |
Molecular pharmacology |
Medium |
14978255
|
| 2007 |
FAF1 suppresses IKK activation by interacting with IKKβ via its leucine-zipper domain, disrupting IKK heterocomplex and homocomplex formation and attenuating IKKγ recruitment to IKKβ, thereby inhibiting NF-κB signaling in response to TNF-α, IL-1β, and LPS. |
Co-immunoprecipitation, overexpression and siRNA knockdown with IKK kinase activity assays |
The Journal of biological chemistry |
High |
17684021
|
| 2013 |
FAF1 interacts with VCP complexed with Npl4-Ufd1 heterodimer via its C-terminal UBX domain, and with polyubiquitinated proteins via its N-terminal UBA domain (which recognizes Lys48-linked ubiquitin), promoting endoplasmic reticulum-associated degradation (ERAD). VCP association to the UBX domain regulates ubiquitin binding to the UBA domain. |
Co-immunoprecipitation, structural and biochemical analysis, ERAD functional assays |
The Journal of biological chemistry |
High |
23293021
|
| 2011 |
Crystal structure of human FAF1 UBX domain at 2.9 Å resolution reveals a conserved FcisP touch-turn motif in the p97/VCP-binding region, with two conformations of this motif suggesting a conformational change upon binding to p97/VCP N domain. |
X-ray crystallography |
Biochemical and biophysical research communications |
High |
21414298
|
| 2014 |
FAF1 binds p97 stably in a stoichiometry of 3–6 FAF1 per p97 hexamer; cryo-EM reconstruction at 17 Å shows FAF1 positioned above the p97 ring. |
Cryo-EM, native mass spectrometry, analytical ultracentrifugation |
The Journal of biological chemistry |
High |
24619421
|
| 2013 |
Parkin acts as an E3 ubiquitin ligase that ubiquitinates FAF1 both in vitro and in cells; PD-linked parkin mutations disrupt FAF1 ubiquitination and degradation, elevating FAF1 expression. Wild-type parkin abolishes FAF1-mediated cell death, but PD-linked mutants do not. FAF1 accumulates in the substantia nigra in MPTP-treated mice, and FAF1-deficient mice show attenuated MPTP-induced dopaminergic cell loss. |
In vitro ubiquitination assay, cell-based ubiquitination assay, mouse model (gene trap and MPTP treatment), behavioral and biochemical readouts |
Human molecular genetics |
High |
23307929
|
| 2013 |
The UAS domain of FAF1 polymerizes upon interaction with long-chain unsaturated fatty acids; specific mutations in positively charged surface residues of the UAS domain prevent this polymerization. |
In vitro polymerization assay, site-directed mutagenesis, cell-based fatty acid regulation assay |
Journal of lipid research |
High |
23720822
|
| 2014 |
FAF1 contains a non-canonical FFAT motif that allows direct interaction with the MSP domain of VAPB, thereby mediating VAPB interaction with p97. FAF1 knockdown strongly reduces VAPB interaction with ubiquitinated proteins. |
Co-immunoprecipitation, direct binding assays, siRNA knockdown |
BMC biology |
Medium |
24885147
|
| 2016 |
FAF1/UBXN-3 binds to the licensing factor CDT-1 and ubiquitylated proteins to promote CDC-48/p97-dependent turnover and disassembly of DNA replication factor complexes at the fork. Inactivation of FAF1/UBXN-3 stabilizes CDT-1 and CDC-45/GINS on chromatin, causing replication fork defects, replication stress, and genome instability. |
Genetic knockdown/knockout in C. elegans and human cells, chromatin fractionation, replication fork dynamics assays |
Nature communications |
High |
26842564
|
| 2016 |
Upon oxidative stress, FAF1 translocates from the cytoplasm to the nucleus and promotes catalytic activation of PARP1 through direct physical interaction, driving PARP1-dependent necrotic cell death (energetic collapse, mitochondrial depolarization, AIF nuclear translocation). FAF1 overexpression in mouse ventral midbrain promotes PARP1 activation and dopaminergic neurodegeneration in the MPTP model. |
Subcellular fractionation and immunofluorescence, co-immunoprecipitation, siRNA knockdown with cell death assays, AAV-mediated overexpression in mouse brain |
Cell death and differentiation |
High |
27662363
|
| 2017 |
FAF1 destabilizes TGF-β type II receptor (TβRII) on the cell surface by recruiting the VCP/E3 ligase complex. AKT directly phosphorylates FAF1 at Ser582, disrupting the FAF1-VCP complex and reducing FAF1 at the plasma membrane, resulting in increased TβRII surface levels and enhanced TGF-β signaling. |
Co-immunoprecipitation, in vitro kinase assay, FAF1 knockout mouse model, EMT and metastasis assays, MMTV-PyMT transgenic mouse model |
Nature communications |
High |
28443643
|
| 2018 |
FAF1 forms aggregates that negatively regulate MAVS by competing with TRIM31 for MAVS association, thereby antagonizing K63-linked polyubiquitination and aggregation of MAVS. Upon viral infection, IKKε directly phosphorylates FAF1 at Ser556, triggering FAF1 de-aggregation and lysosomal degradation, relieving FAF1-dependent suppression of MAVS. FAF1 knockout mice show enhanced innate antiviral signaling and reduced viral load. |
Co-immunoprecipitation, in vitro kinase assay, FAF1 knockout mice, viral infection models, ubiquitination assays |
Cell host & microbe |
High |
30472208
|
| 2019 |
FAF1 contains two SUMO-interacting motifs (SIMs) that are crucial for interaction with sumoylated mineralocorticoid receptor (MR) and for repressing aldosterone-activated MR transactivation. FAF1/SIM-mediated MR repression involves inhibition of MR N/C interactions and promotion of MR polyubiquitination and degradation. Silencing FAF1 increases aldosterone-induced MR target gene expression. |
Mutagenesis of SIM motifs, co-immunoprecipitation, transactivation reporter assays, siRNA knockdown |
Biochimica et biophysica acta. Molecular cell research |
Medium |
30935967
|
| 2020 |
FAF1 missense variants (p.Asp371Asn and p.Arg85Pro) encode unstable FAF1 proteins; expression of these variants in CRC cells causes resistance to apoptosis, accumulation of β-catenin in the cytoplasm, and NF-κB nuclear translocation, establishing FAF1 as a functional regulator of both apoptosis and Wnt/NF-κB pathways. |
CRISPR/Cas9 gene editing, transfection of missense variants, apoptosis assays, Western blot, NF-κB and Wnt reporter assays |
Gastroenterology |
Medium |
32179092
|
| 2021 |
VCP/FAF1 facilitates extraction of SUMOylated and ubiquitylated DNA replication proteins from chromatin. FAF1 inactivation combined with USP7 inactivation is synthetically lethal in C. elegans and mammalian cells, and USP7/VCP inhibitors show synergistic toxicity, establishing a functional cooperation between FAF1-dependent chromatin extraction and USP7-mediated deubiquitylation at replication forks. |
Genetic epistasis (double KO/KD), chromatin fractionation, proteasome inhibitor treatment, pharmacological synergy assays in C. elegans and mammalian cells |
Cell reports |
High |
34644576
|
| 2022 |
FAF1 assembles a globular structure that sequesters free polyunsaturated fatty acids (PUFAs) into a hydrophobic core via its UAS domain interaction, preventing PUFA peroxidation by limiting iron access. FAF1 knockout mice develop hepatic injury on PUFA-enriched diet, and FAF1-deficient cells become sensitive to ferroptosis upon PUFA exposure, placing FAF1 upstream of GPX4 in ferroptosis protection. |
FAF1 knockout cell lines and mice, ferroptosis assays, structural biochemistry (globular assembly), lipid peroxidation assays |
Proceedings of the National Academy of Sciences of the United States of America |
High |
35467977
|
| 2014 |
FAF1 interacts with CD40 via its N-terminal FID domain, binding to the TRAF6-binding domain of CD40's cytoplasmic tail. CD40 ligation induces FAF1 expression in an NF-κB-dependent manner, and FAF1 in turn suppresses CD40-induced NF-κB activation via a negative feedback loop; FAF1 knockdown prolongs CD40-induced NF-κB activation. |
Yeast two-hybrid, in vitro and in vivo co-immunoprecipitation, siRNA knockdown, NF-κB reporter assays |
Cell death & disease |
Medium |
24810049
|
| 2015 |
HSP70 interacts with FAF1 via its N-terminal 1–120 amino acid sequence and competitively inhibits FAF1 binding to Fas, suppressing caspase-8 activation and apoptosis. An N-terminal HSP70 deletion mutant (HSP70-ΔN) cannot interact with FAF1 and fails to attenuate stress-induced apoptosis. |
Co-immunoprecipitation, competitive binding assays, overexpression of domain deletion mutants, caspase activity assays |
Cell stress & chaperones |
Medium |
25935138
|
| 2017 |
XIAP interacts with FAF1, promotes ubiquitination of FAF1, blocks FAF1-mediated cell death by interfering with the caspase cascade, and directly interferes with FAF1's inhibition of NF-κB. Conversely, FAF1 attenuates XIAP-mediated NF-κB activation without affecting XIAP's anti-apoptotic activity. |
Co-immunoprecipitation, domain mapping, ubiquitination assay, cell death assays, NF-κB reporter assays |
Biochimica et biophysica acta. Molecular cell research |
Medium |
28414080
|
| 2018 |
FAF1 functions upstream of JNK1 upon ischemic insult; FAF1 physically interacts with JNK1 and promotes JNK1-mediated mitochondrial dysfunction and necrotic cell death. Conditional FAF1 knockout in retinal cells (Dkk3-Cre;Faf1flox/flox mice) attenuates JNK1 activation and ameliorates ischemic retinal cell death. |
Immunoprecipitation, conditional KO mouse model, retinal ischemia model with IOP elevation, JNK1 activity assays |
Cell communication and signaling |
High |
30200976
|
| 2020 |
FAF1 is secreted from neuronal cells via both BFA-resistant secretory pathways (vesicle-free form) and as exosome cargo. Extracellular FAF1 is taken up by neighboring cells via endocytosis and induces cell death through apoptotic and necrotic pathways. FAF1 also increases the number of exosomes, suggesting a regulatory role in exosome biogenesis. |
Conditioned medium analysis, ultracentrifugation exosome isolation, electron microscopy, nanoparticle tracking analysis, transwell transmission assay, flow cytometry |
Cell communication and signaling |
Medium |
32831099
|
| 2024 |
VCP controls ubiquitin-proteasomal degradation of KCC2 dependent on FAF1 recruitment; propofol-induced degradation of KCC2 is inhibited by FAF1 knockout, demonstrating that FAF1 is required for VCP-mediated targeting of ubiquitinated KCC2 to the proteasome. |
VCP inhibitor (DBeQ), VCP and FAF1 knockout (sgRNA), co-immunoprecipitation, in vivo VPM microinjection in mice |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
39793039
|
| 2024 |
SAP130 sumoylation at Lys794, Lys878, and Lys932 is required for its interaction with FAF1; FAF1 promotes SAP130 polyubiquitination and degradation in a sumoylation-dependent manner, thereby counteracting SAP130's transcriptional repression activity. |
In vitro and in vivo sumoylation assays, mutagenesis of SUMO acceptor sites, co-immunoprecipitation, polyubiquitination assay, transcriptional reporter assays |
BMC molecular and cell biology |
Medium |
38172660
|
| 2025 |
Extracellular GMFB activates FAF1 via the FAS receptor to promote degradation of the H+-ATPase ATP6V1A, leading to lysosomal dysfunction in retinal pigment epithelial cells. FAS siRNA and antagonist partially reverse GMFB-induced lysosomal damage, establishing a FAS-FAF1-ATP6V1A signaling axis. |
siRNA library screening, immunofluorescence, molecular docking, co-immunoprecipitation, intravitreal injection in vivo |
International journal of biological macromolecules |
Medium |
40490177
|
| 2026 |
FAF1 accelerates p97/VCP-mediated unfolding of K48-ubiquitinated substrates by using its p97-bound C-terminal UBX domain to anchor a long helix that braces the UT3 domain of Ufd1, stabilizing the Ufd1-Npl4 cofactor for ubiquitin unfolding and engagement by the ATPase motor. This mechanism stimulates proteasomal degradation. |
In vitro reconstituted unfolding system with human components, FRET-based assays, cryo-EM structure determination, mutagenesis |
Cell reports |
High |
41790892 42228561
|
| 2017 |
FAF1 regulates CD40-induced NF-κB activation via a negative feedback loop: CD40 ligation induces FAF1 expression in an NF-κB-dependent manner, and FAF1 in turn suppresses CD40-induced NF-κB activation through interaction with CD40 via its FID domain. (Note: this finding overlaps with PMID:24810049 above and is the same discovery.) |
Yeast two-hybrid, Co-IP, NF-κB reporter, siRNA knockdown |
Cell death & disease |
Medium |
24810049
|
| 2011 |
FAF1 expression is required for cranial neural crest (CNC) differentiation in zebrafish; faf1 knockdown causes pharyngeal cartilage defects and jaw abnormality due to failure of CNC to differentiate and express cartilage markers sox9a and col2a1. Rescue with faf1 mRNA restores the phenotype. |
Zebrafish morpholino knockdown, mRNA rescue, in situ hybridization for cartilage markers |
American journal of human genetics |
Medium |
21295280
|
| 2017 |
FAF1 impairs autophagic flux in dopaminergic neurons, leading to α-synuclein accumulation; pharmacological targeting of FAF1 with KM-819 restores autophagic flux and reduces α-synuclein accumulation in FAF1-overexpressing neuronal cells and in A53T α-synuclein transgenic mice. |
FAF1 overexpression via AAV, pharmacological inhibition (KM-819), autophagic flux assays, α-synuclein quantification, transgenic mouse model |
ACS chemical neuroscience |
Medium |
35230076
|
| 2017 |
NLRP2 protein physically interacts with FAF1 in mouse oocytes and preimplantation embryos; knockdown of either Nlrp2 or Faf1 interferes with NLRP2-FAF1 complex formation and causes developmental arrest in early embryogenesis. |
Co-immunoprecipitation from oocytes and embryos, immunofluorescence colocalization, zygote knockdown |
Reproduction (Cambridge, England) |
Medium |
28630100
|